default author photo

Amanda Psyrri

- Section of Medical Oncology

Athens

Greece

SCHOLARLY PAPERS

4

DOWNLOADS

891

TOTAL CITATIONS

2

Scholarly Papers (4)

1.

Nivolumab Added to Cisplatin-Radiotherapy Versus Cisplatin-Radiotherapy Alone after Surgery for Patients with Squamous Cell Carcinoma of the Head and Neck at High-Risk of Relapse (GORTEC 2018-01 NIVOPOST-OP): A Randomised, Open-Label, Phase 3 Trial

Number of pages: 26 Posted: 26 Jun 2025
Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Institut de cancérologie Strasbourg Europe (ICANS), University of Lille II - Centre Oscar Lambret, Centre Léon Berard, Medical Oncology, Institute of Cancerology of Lorraine - Alexis Vautrin, Hopital Nord Franche-Comté de Montbéliard, Centre Antoine Lacassagne, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Maria Skłodowska-Curie Institute of Oncology, CHU UCL Namur Site Sainte Elisabeth, Institut Claudius Regaud, Centre François Baclesse, CHRU Bretonneau, Sainte Catherine Institute, Centre Hospitalier de Bretagne Sud, University of Nantes - CHU Nantes, CHU Poitiers, Institut de Cancérologie Jean Godinot, Centre Henri Becquerel - Department of Radiation Oncology, Victor Hugo Clinic, Gustave Roussy, Centre Hospitalier de Valence, Institut Curie Hopital René Huguenin, Centre Hospitalier Pierre Bénite, ICO-Site René Gauducheau, Centre Marie Curie-Hôpital Privé Drôme Ardèche, Centre Hospitalier Départemental de Vendée, University of Bordeaux - CHU de Bordeaux, Hôpital Privé Sainte Marie, Gustave Roussy, Institut Català d'Oncologia, Hospital Universitario Cruces - Medical Oncology Department, Gustave Roussy, Gustave Roussy - Department of Head and Neck Oncology, Hospital Regional Universitario de Málaga, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse - Department of Radiation Oncology, Greater Poland Cancer Center - Gielkopolskie Centrun Onkologii im. Marii Curie-Sklodowskiej, - Section of Medical Oncology, Autonomous University of Barcelona - Medical Oncology Department and Gustave Roussy
Downloads 571 (123,051)
Citation 2

Abstract:

Loading...

Squamous cell carcinoma of head and neck, surgery, post-operative, chemoradiotherapy, nivolumab

2.

Endothelial Glycocalyx Integrity in Oncological Patients

Number of pages: 17 Posted: 18 Jan 2022
- 2nd Department of Cardiology, - 2nd Department of Cardiology, Agios Savvas - Cardiology Department, - 2nd Department of Cardiology, - Section of Medical Oncology, - Section of Medical Oncology, - Hematology Division, - Hematology Division, - 2nd Department of Cardiology, - 2nd Department of Cardiology, - Section of Medical Oncology, - 2nd Department of Cardiology and - 2nd Department of Cardiology
Downloads 136 (540,814)

Abstract:

Loading...

cancer, cardiotoxicity, Endothelial function, glycocalyx

3.

Avelumab in Combination with Standard of Care Chemoradiotherapy Versus Chemoradiotherapy Alone in Patients with Locally Advanced SCCHN: A Randomised, Double-Blind, Phase 3 Trial

Number of pages: 28 Posted: 09 Sep 2020
Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, University of Pittsburgh - Hillman Cancer Center, - Section of Medical Oncology, Harvard University - Department of Medical Oncology, National Cancer Center Hospital East, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), NHS Foundation Trust - Royal Marsden Hospital, National Yang Ming University - Taipei Veterans General Hospital, Changhua Christian Hospital - Department of Radiation Oncology, University of Oklahoma - Stephenson Cancer Center, Instituto Português de Oncologia de Coimbra Francisco Gentil, Semmelweis University - Onkológiai Tanszék, Centre Hospitalier Prive Saint Grégoire - CHP Saint Grégoire, Costa del Sol Hospital - Department of Medical Oncology, Fudan University - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Budgetary Institution of Healthcare of the Omsk Region - Clinical Oncology Dispensary, Pfizer AG, Pfizer, Inc., Pfizer, Inc. and University of California, San Diego (UCSD) - Moores Cancer Center
Downloads 97 (709,832)

Abstract:

Loading...

avelumab, JAVELIN Head and Neck 100, PD-L1, squamous cell carcinoma of the head and neck, immunotherapy, radiation, chemotherapy

4.

B-Cell Infiltration is Associated with Survival Outcomes Following Programmed Cell Death Protein 1 Inhibition in Head and Neck Squamous Cell Carcinoma

Number of pages: 35 Posted: 20 Sep 2023
National & Kapodistrian University of Athens, University of Lausanne - Lausanne University Hospital, National & Kapodistrian University of Athens, Agios Savvas - Cardiology Department, - Section of Medical Oncology, National & Kapodistrian University of Athens, National & Kapodistrian University of Athens, University of Lausanne - Lausanne University Hospital, Yale University, Yale University, University of Lausanne - Lausanne University Hospital, National & Kapodistrian University of Athens, - Section of Medical Oncology, National & Kapodistrian University of Athens, National & Kapodistrian University of Athens, Yale University, University of Lausanne - Lausanne University Hospital, University of Lausanne - Lausanne University Hospital, National & Kapodistrian University of Athens and - Section of Medical Oncology
Downloads 87 (771,553)

Abstract:

Loading...

B-Lymphocytes, Programmed Cell Death 1 Receptor, Head and Neck Neoplasms, Immunotherapy, Lymphocytes, Tumor-Infiltrating